Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BiRd Regimen in First Relapsed Multiple Myeloma
NCT04063189Phase 2Unknown
- Sponsor
- The First Hospital of Jilin University
- Start
- Mar 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clarithromycin in multiple myeloma (MM), sponsored by The First Hospital of Jilin University. Status: unknown.
02
Drugs
clarithromycin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT04063189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04063189.